Boohoo Group trading in the UK remains resilient says Zeus Capital
Boohoo Group plc (LON:BOO) Q4 revenue growth of +7% YOY is ahead of ZC est. of +4.9%. Moderation in growth over FY22 reflects tough prior year comps, with the closure
Boohoo Group plc (LON:BOO) Q4 revenue growth of +7% YOY is ahead of ZC est. of +4.9%. Moderation in growth over FY22 reflects tough prior year comps, with the closure
Strix Group plc (LON:KETL), the global leader in the design, manufacture and supply of kettle safety controls and other complementary water temperature management components will be conducting an investor presentation covering their
Zeus Capital expect Big Technologies plc (LON:BIG) to outperform in the current macro environment. In general, Western sanctions on Russia are reducing corporate sector revenues and rising inflation is squeezing
Boohoo Group plc (LON:BOO) has provided an update for the three and twelve months ended 28 February 2022. The Group has delivered net sales growth in the fourth quarter of 7% (2
City of London Investment Group plc (LON:CLIG), a leading specialist asset management group offering a range of institutional and retail products investing primarily in closed-end funds, stated that it has been
Flowtech Fluidpower plc (LON:FLO) has announced the appointments of James Brooke and Ailsa Webb as Non-Executive Directors of the Group with immediate effect. James has had successful City roles in
CentralNic Group Plc (LON:CNIC) is the topic of conversation when Bob Liao Director and Research Analyst at Zeus Capital joins DirectorsTalk Interviews. Bob provides us with an overview of VGL, explains how the
Vertu Motors plc (LON:VTU) is the topic of conversation when Director and Head of Research at Zeus Capital Mike Allen joins DirectorsTalk. Mike explains how the company performed during the period, any changes
Guild Esports plc (LON:GILD; OTCQB: GULDF), a global team organisation and lifestyle brand, has announced that it has won its fifth major trophy after its Fortnite pro-player, Henrik Mclean (‘Hen’), achieved
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has announced the signing of a new commercial follow-on contract with a world-leading medical research organisation based in the US, to